NCT03254121View on ClinicalTrials.gov

Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response

CompletedOBSERVATIONAL
Enrollment

93

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

September 1, 2020

Study Completion Date

September 1, 2020

Conditions
Hepatocellular CarcinomaHepatitis C
Trial Locations (1)

Unknown

Karolinska Institutet, Stockholm

Sponsors

Collaborators (1)

AbbVie
All Listed Sponsors
collaborator

AbbVie

INDUSTRY

lead

Karolinska Institutet

OTHER